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Background
The ability of CD8+ T lymphocytes to recognize a diversity
of mutant forms of an HIV epitope is of central impor-
tance in the immune containment of this virus. The
present studies were pursued to determine the mechanism
employed by CD8+ T lymphocytes to recognize mutant
viruses. In particular, we sought to determine whether
mutant sequences are recognized by distinct CD8+ T lym-
phocyte populations or whether individual clonal popu-
lations of CD8+ T lymphocytes recognize a diversity of
mutant sequences.
Methods
We employed flow cytometry, Vβ repertoire analysis, and
CDR3 sequencing methodologies to characterize the
clonal diversity of CD8+ T lymphocytes that recognize
variant forms of the HIV-1 envelope (Env) p41A epitope
generated after infection by SHIV-89.6P or elicited by
HIV-1 89.6P Env immunization of Mamu-A*01+ rhesus
monkeys. To evaluate the capacity of the CD8+ T lym-
phocytes to recognize genetically diverse isolates of HIV-
1, we employed a series of tetramers constructed with var-
iants of the p41A epitope of HIV-1 Env. To define which T
cell receptor mediated the recognition of each specific var-
iant p41A, we isolated variant p41A-specific CD8+ T lym-
phocyte populations and analyzed the expression of 46
Vβ families and subfamilies genes. We then determined
the precise clones employed for the recognition of each
variant epitope peptide through CDR3 sequencing.
Results
In both the infected and the vaccinated monkeys, we
observed clonotypes capable of recognizing the majority
of the variant epitope peptides.
Conclusion
These data show that exposure to a single HIV-1 Env
sequence can generate clonotypes capable of recognizing
multiple variant forms of HIV-1 Env. Such Env-specific
CD8+ T lymphocytes should be able to confer potent,
effective protection against a diverse spectrum of circulat-
ing viruses.
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